U.S. regulator asks for immediate recall of all versions of Zantac, Canada yet to follow suit

TORONTO — The U.S. Food and Drug Administration announced Wednesday that it is asking manufacturers and pharmacies to cease production and sale of over-the-counter Zantac, a medication that treats heartburn, due to potential contamination. According to the FDA, the medication could contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA). An investigation into the levels of NDMA within ranitidine medication has been...

READ MORE U.S. regulator asks for immediate recall of all versions of Zantac, Canada yet to follow suit

Recall of generic Xanax medication affects U.S., not Canada

TORONTO — Pharmaceutical company Mylan has issued a voluntary recall of their generic Xanax medication called alprazolam tablets in the United States. The company’s head of communications in North America confirmed to CTVNews.ca that the recall does not affect medication in Canada. “The recall is specific to one lot distributed in the U.S.,” said Lauren Kashtan in an email.  In...

READ MORE Recall of generic Xanax medication affects U.S., not Canada

Federal Oversight For Plaintiff Lawyer Advertising | Drug

We write mostly about decisions in cases, with those mostly coming from judges. Occasionally, we will also comment on articles, amicus briefs, and official government pronouncements. We cannot remember the last time we explored a press release. In today’s political environment, speculation about what is contained in documents that purportedly exist but we cannot see can be time-consuming and often pointless...

READ MORE Federal Oversight For Plaintiff Lawyer Advertising | Drug